Epidemiology of Human Infectious Diseases During Health Crises in Low- and Middle-Income Countries
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: 20 December 2025 | Viewed by 27
Special Issue Editors
Interests: parasitology; medical entomology; epidemiology
Special Issues, Collections and Topics in MDPI journals
2. Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat, Morocco
Interests: epidemiology of infectious disease; COVID19; measles; tuberculosis; malaria; VIH
Special Issue Information
Dear Colleagues,
The epidemiology of infectious human diseases during health crises in low- and middle-income countries is a critical and highly complex issue.
Outside of health crises, human infections in these countries are disproportionately distributed due to pre-existing vulnerabilities and limited response capacities. The burden of morbidity and mortality is considerably higher than in high-income countries. This situation arises from a complex interplay of socio-economic, environmental, and health system factors, as well as other factors of infectious disease.
When health crises occur, low- and middle-income countries are particularly vulnerable, and the impact of human infection is often greater than in high-income countries. Over the last ten years, the world, and low- and middle-income countries in particular, has experienced numerous health crises that have impacted the epidemiology of infectious diseases and worsened countries' health. Examples include the Ebola epidemic, the measles epidemic, the Mpox disease health crisis, and the ongoing global pandemic of SARS-CoV-2.
Prof. Dr. Samia Boussaa
Prof. Dr. Youssef Ikken
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epidemiology of infectious disease
- COVID19
- measles
- tuberculosis
- malaria
- VIH
- bacterial meningitis
- infectious diseases
- antibioresistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
